High Efficacy of SLS009 Observed in 67% of ASXL1 Mutated Solid Cancers vs 0% in Non-ASXL1 Mutated Cancers – - ASXL1 Mutations Predictably Identified in Colorectal Cancer (CRC MSI-H) and Non-Small Cell ...
Johnson & Johnson unveils ‘India Detects to Defeat’ initiative to urge for early lung cancer detection and testing: Our Bureau, Mumbai Wednesday, November 27, 2024, 14:45 Hrs ...